Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 105 of 111, showing 5 Applications out of 555 total, starting on record 521, ending on 525

# Protocol No Study Title Investigator(s) & Site(s)

521.

ECCT/25/04/03   PRETERM AFRICA STUDY
    Pragmatic Evaluation of Therapies to Enhance Respiratory Management in Preterm Infants in Africa   
Principal Investigator(s)
1. Nayirat Mohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
View

522.

ECCT/25/04/04   LIMIT
    A Low INR to Minimize bleeding with mechanical valves Trial (LIMIT)   
Principal Investigator(s)
1. Anthony KIBUKA Gikonyo
Site(s) in Kenya
The Karen Hospital
 
View

523.

ECCT/25/04/07   Server migration
    Server Migration   
Principal Investigator(s)
1. Server Migration Server Migration
Site(s) in Kenya
Server Migration
 
View

524.

ECCT/25/05/01   Sparkle Study Site 1403
    A phase III, Multicenter, Randomized, Placebo Controlled, Double blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) versus placebo, with or without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients with Frequent Vaso-Occlusive CrisesA phase III, Multicenter, Randomized, Placebo Controlled, Double blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) versus placebo, with or without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients with Frequent Vaso-Occlusive Crises   
Principal Investigator(s)
1. Fredrick Chite Asirwa
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
2. Ahero Clinical trials Unit (Kisumu county)
3. International Cancer institute (Uasin Gishu county)
4. Kondele Childrens Hospital (Kisumu county)
5. KEMRI/CRDR KEMRI Clinical Research Annex (Siaya county)
6. Gertrudes Children’s Hospital (Nairobi City county)
 
View

525.

ECCT/25/05/02   Hibiscus 2 - Site 251
    A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. Site 251 - Ahero Clinical Trails Unit, CREATES Strathmore University (Kisumu county)
 
View